|
APC Natural Research |
|
|
Research Analysis |
|
Phase IV Objective:
For a period of two years post ingestion, monitor all horses given Sefacon™ to establish antibody levels, potential T-cell activity and establish potential re-infection rates.
Phase IV Conclusion:
Antibody levels varied indicating re-exposure to S. Neurona protozoa. Although antibody levels elevated and decreased, no equine became symptomatic.
EPM Analysis Phase I EPM Analysis Phase II EPM Analysis Phase III
EPM Analysis Phase IV Conclusion Report Owner Testimonials!
For information on obtaining Sefacon™
contact
Endocrine Technologies, Inc or Indiana
Horse Rescue
